Cathflo activase and Novolog drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among 22 people who take Cathflo activase and Novolog. Common interactions include dyspepsia among females, and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Cathflo activase and Novolog have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

On Sep, 25, 2023

22 people who take Cathflo activase and Novolog together, and have interactions are studied.

What is Cathflo activase?

Cathflo activase has active ingredients of alteplase. Currently, eHealthMe is studying from 1,322 Cathflo activase users.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is used in diabetes. Currently, eHealthMe is studying from 54,192 Novolog users.

Number of Cathflo activase and Novolog reports submitted per year:

Cathflo activase and Novolog drug interactions.

Common Cathflo Activase and Novolog drug interactions by gender *:


  1. Dyspepsia
  2. Glycosylated haemoglobin increased
  3. Anaemia
  4. Blood albumin decreased
  5. Blood calcium decreased
  6. Blood urea increased
  7. Bradycardia
  8. Cardiac arrest
  9. Decreased activity
  10. Dehydration


  1. Anxiety
  2. Arthralgia
  3. Intervertebral disc degeneration
  4. Intervertebral disc protrusion
  5. Light chain analysis increased
  6. Myelitis transverse
  7. Myofascial pain syndrome
  8. Osteoarthritis
  9. Osteonecrosis of jaw
  10. Osteoporosis

Common Cathflo Activase and Novolog drug interactions by age *:






  1. Acute respiratory distress syndrome
  2. Anaemia
  3. Asthenia
  4. Atrial flutter
  5. Blood glucose increased
  6. Blood urea increased
  7. Body height below normal
  8. Bone disorder
  9. Bradycardia
  10. Chronic kidney disease




  1. Dyspnoea
  2. Fatigue
  3. Pain
  4. Pulmonary congestion
  5. Wheezing


  1. Cough
  2. Decreased appetite
  3. Dyspepsia
  4. Dyspnoea
  5. Fatigue
  6. Bacterial infection
  7. Blood albumin decreased
  8. Blood calcium decreased
  9. Decreased activity
  10. Glycosylated haemoglobin increased


  1. Muscle spasms
  2. Viith nerve paralysis
  3. Acute respiratory failure
  4. Alanine aminotransferase decreased
  5. Ammonia increased
  6. Aphasia
  7. Atelectasis
  8. Back pain
  9. Bacterial sepsis
  10. Band neutrophil percentage increased


  1. Pulse absent
  2. Seizure
  3. Enterobacter bacteraemia
  4. Hyperbilirubinaemia
  5. Interstitial lung disease
  6. Muscle twitching
  7. Myasthenia gravis
  8. Oedema peripheral
  9. Paraneoplastic syndrome
  10. Pneumonia viral

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 10 people, 45.45%
  2. Pain: 6 people, 27.27%
  3. Nausea (feeling of having an urge to vomit): 5 people, 22.73%
  4. Constipation: 5 people, 22.73%
  5. Stress And Anxiety: 3 people, 13.64%
  6. Sleep Disorder: 3 people, 13.64%
  7. Nausea And Vomiting: 3 people, 13.64%
  8. Indigestion: 3 people, 13.64%
  9. Cystic Fibrosis (disease of the secretary glands): 3 people, 13.64%
  10. Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cathflo activase and Novolog?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Cathflo activase side effects:

Browse all side effects of Cathflo activase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Novolog side effects:

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cathflo activase interactions:

Browse all interactions between Cathflo activase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Novolog interactions:

Browse all interactions between Novolog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alteplase and insulin aspart recombinant (the active ingredients of Cathflo activase and Novolog, respectively), and Cathflo activase and Novolog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cathflo activase and Novolog.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: